| Typicality: | 0.309 |
| Saliency: | 0.344 |
| in the future | 5 | temporal |
| for type i sma patients | 4 | transitive-object |
| potentially | 2 | manner |
| protein → have → therapeutic potential | 12 |
| protein → be used as → therapeutic targets | 3 |
| protein → be → therapeutic targets | 3 |
| protein → serve as → therapeutic targets | 3 |
| protein → be → potential therapeutic targets | 3 |
| protein → be → potential therapeutic target | 3 |
| negative | neutral | positive |
| 0.020 | 0.453 | 0.527 |
| Raw frequency | 27 |
| Normalized frequency | 0.344 |
| Modifier score | 0.500 |
| Perplexity | 203.969 |